840.5000 -11.70 (-1.37%)
NSE Dec 29, 2025 15:05 PM
Volume: 21,283
 

840.50
-1.37%
BOB Capital Markets Ltd.
US and ROW sales grew above our estimates of 5% and 13% respectively, reporting growth of 10% each
Alembic Pharmaceutic.. has an average target of 1028.50 from 4 brokers.
More from Alembic Pharmaceuticals Ltd.
Recommended